BICLUSTER_ID : UPREG-10
PATHOGENS /4/ : escherichia coli,bifidobacterium bifidum,lactobacillus acidophilus,ehrlichia chaffeensis
TARGETS /16/ : CCL20, PLAT, CCL2, CD40, TNFRSF1B, CD80, MTHFD2, CCL5, PIM1, NFKB1, STAT1, IL12B, IL6, IL1B, CASP1, TNF
Gene SetLeading Edge Genes
NETPATH IL 2 PATHWAY UPPFKFB3, TNFRSF1B, NMI, SOCS3, TRAFD1, MTHFD2, IFI44, SOCS1, SLAMF1, IFIT1, STAT1, SP100, CD69, TNFSF10, GADD45G, IL10, TRIM21, IL6, IL1B, CASP1, PBEF1, IRF1, UPP1, TNF, MX1
NETPATH IL 1 PATHWAY UPCCL20, MMP14, CCL2, MTHFD2, CCL7, PTGES, MT2A, CXCL2, NFKB1, BIRC3, CXCL1, IL1A, CXCL5, IL6, IL1B, PBEF1
NCI IL23PATHWAYSOCS3, STAT1, IL6, IL1B, CXCL1, CCL2, TNF
NETPATH IL 4 PATHWAY DOWNSTAT1, UBE2L6, GADD45B, CCL20, CCL2, TNFSF10, GBP2, TLR3, IL6, GEM, CXCL2, IRF1, TNF, MX1
NCI IL27PATHWAYSTAT1, IL6, IL12B, IL1B, STAT2, EBI3, TNF
ST TUMOR NECROSIS FACTOR PATHWAYNFKB1, BIRC3, TNFAIP3, NFKB2, BIRC2, TNFRSF1B, TNF
NETPATH IL 4 PATHWAY UPNFKB1, REL, ETV3, IBRDC3, CCL2, CH25H, IL10, SOCS3, IL1RN, IL6, RSAD2, SOCS1, RIPK2, UPP1
NETPATH IL 3 PATHWAY UPSOCS3, CCL7, IL1B, CD69, SOCS1, CCL2, TNF
NETPATH IL 6 PATHWAY UPSTAT1, GADD45B, CXCL1, JUNB, MAP3K8, NMI, SOCS3, SOCS1, PIM1, IRF1, PRDM1, MX1, TNF
NETPATH IL 7 PATHWAY UPCXCL5, FAS, CXCL1, CCL5, CCL19, CXCL2, CD80
GERY CEBP TARGETSGADD45B, CXCL1, EREG, JUNB, PLAT, GADD45G, ATF3, PIM1
NCI IL12 2PATHWAYSTAT1, GADD45B, IL1B, SOCS1, RIPK2, GADD45G
NETPATH IL 5 PATHWAY UPPLSCR1, BIRC3, REL, CD69, CCL2, IL1A, TBK1, IL1B, UPP1, PRDM1, CASP4
NCI CD40 PATHWAYTRAF1, NFKB1, BIRC3, TNFAIP3, CD40, BIRC2
NETPATH IL 9 PATHWAY UPSOCS3, CCL7, CCL2, JUNB
NCI IL12 STAT4PATHWAYIRF1, CD80
BIOCARTA IL10 PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
PUJANA BRCA2 PCC NETWORK
WEINMANN ADAPTATION TO HYPOXIA DN
BIOCARTA IL6 PATHWAY
KEGG GRAFT VERSUS HOST DISEASE
NCI TNFPATHWAY
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
KRASNOSELSKAYA ILF3 TARGETS UP
RASHI RESPONSE TO IONIZING RADIATION 2
RADAEVA RESPONSE TO IFNA1 UP
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
HINATA NFKB TARGETS KERATINOCYTE UP
RUTELLA RESPONSE TO CSF2RB AND IL4 UP
SOTIRIOU BREAST CANCER GRADE 1 VS 3 UP
CORUM CD20-LCK-LYN-FYN-P75/80 COMPLEX RAJI HUMAN B CELL LINE
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
MARKEY RB1 ACUTE LOF UP
XU AKT1 TARGETS 6HR
KANG DOXORUBICIN RESISTANCE UP
KEGG TYPE II DIABETES MELLITUS
LIU VAV3 PROSTATE CARCINOGENESIS UP
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
BIOCARTA CD40 PATHWAY
DAUER STAT3 TARGETS DN
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN
DEBOSSCHER NFKB TARGETS REPRESSED BY GLUCOCORTICOIDS
AMIT EGF RESPONSE 120 HELA
DANG REGULATED BY MYC DN
BIOCARTA RANKL PATHWAY
MCLACHLAN DENTAL CARIES UP
IIZUKA LIVER CANCER PROGRESSION G1 G2 UP
PODAR RESPONSE TO ADAPHOSTIN UP
KYNG DNA DAMAGE UP
CORUM ABIN2-NFKB1-MAP3K8 COMPLEX
LEE LIVER CANCER E2F1 UP
HELLER SILENCED BY METHYLATION UP
BOWIE RESPONSE TO TAMOXIFEN
GOZGIT ESR1 TARGETS DN
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
WONG ENDMETRIUM CANCER UP
FURUKAWA DUSP6 TARGETS PCI35 UP
CORUM REL-MAP3K8-RELA-TNIP2-PAPOLA COMPLEX
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
REACTOME G ALPHA I SIGNALLING EVENTS
NCI ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS
TIAN TNF SIGNALING VIA NFKB
ZHANG PROLIFERATING VS QUIESCENT
HUMMEL BURKITTS LYMPHOMA DN
ST STAT3 PATHWAY
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
KEGG APOPTOSIS
CORUM NFKB1-NFKB2-REL-RELA-RELB COMPLEX
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
HINATA NFKB TARGETS FIBROBLAST UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
NCI ATF2 PATHWAY
GEORGANTAS HSC MARKERS
KEGG PRIMARY IMMUNODEFICIENCY
ZHANG INTERFERON RESPONSE
KONDO PROSTATE CANCER WITH H3K27ME3
CHANG IMMORTALIZED BY HPV31 DN
KEGG ASTHMA
CROONQUIST STROMAL STIMULATION UP
KANG GIST WITH PDGFRA UP
KHETCHOUMIAN TRIM24 TARGETS UP
KIM LRRC3B TARGETS
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
HORIUCHI WTAP TARGETS UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
BIOCARTA SODD PATHWAY
BIOCARTA TH1TH2 PATHWAY
KEGG JAK STAT SIGNALING PATHWAY
BUDHU LIVER CANCER METASTASIS DN
CROONQUIST NRAS SIGNALING DN
TSAI DNAJB4 TARGETS UP
MORI PRE BI LYMPHOCYTE DN
DER IFN BETA RESPONSE UP
CORUM IL12B-IL12RB1-IL12RB2 COMPLEX
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
NETPATH IL 6 PATHWAY
DIRMEIER LMP1 RESPONSE LATE UP
SEIKE LUNG CANCER POOR SURVIVAL
BIOCARTA CYTOKINE PATHWAY
GALI TP53 TARGETS APOPTOTIC UP
MUELLER METHYLATED IN GLIOBLASTOMA
BASSO CD40 SIGNALING UP
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
BIOCARTA BLYMPHOCYTE PATHWAY
ZERBINI RESPONSE TO SULINDAC UP
NCI PTP1BPATHWAY
WU HBX TARGETS 2 DN
MAHADEVAN RESPONSE TO MP470 UP
SMID BREAST CANCER NORMAL LIKE UP
FERRARI RESPONSE TO FENRETINIDE UP
BIOCARTA TID PATHWAY
PUJANA XPRSS INT NETWORK
SANA RESPONSE TO IFNG UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
KEGG LEISHMANIA INFECTION
BOYLAN MULTIPLE MYELOMA PCA1 UP
CHEN HOXA5 TARGETS 9HR UP
LIANG SILENCED BY METHYLATION UP
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
MOSERLE IFNA RESPONSE
FOSTER INFLAMMATORY RESPONSE LPS UP
BIOCARTA ASBCELL PATHWAY
LIU TARGETS OF VMYB VS CMYB DN
PEPPER CHRONIC LYMPHOCYTIC LEUKEMIA UP
CROONQUIST IL6 DEPRIVATION DN
BIOCARTA IL7 PATHWAY
KEGG CYTOSOLIC DNA SENSING PATHWAY
BIOCARTA GRANULOCYTES PATHWAY
BIOCARTA TNFR2 PATHWAY
LINDSTEDT DENDRITIC CELL MATURATION C
HESS TARGETS OF HOXA9 AND MEIS1 DN
ELVIDGE HYPOXIA BY DMOG UP
BIOCARTA IL2RB PATHWAY
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
NCI ACTIVATION OF PRO CASPASE 8
RUTELLA RESPONSE TO HGF UP
HOSHIDA LIVER CANCER LATE RECURRENCE UP
PRAMOONJAGO SOX4 TARGETS UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
BIOCARTA PML PATHWAY
GRAHAM CML DIVIDING VS NORMAL QUIESCENT UP
BIOCARTA NO2IL12 PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING DN
SAKAI CHRONIC HEPATITIS VS LIVER CANCER DN
LINDSTEDT DENDRITIC CELL MATURATION A
NETPATH IL 1 PATHWAY
ELVIDGE HYPOXIA UP
BIOCARTA NKT PATHWAY
BROWNE INTERFERON RESPONSIVE GENES
NCI IL6 7PATHWAY
REACTOME SIGNALING IN IMMUNE SYSTEM
ROETH TERT TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
BIOCARTA LAIR PATHWAY
NUYTTEN NIPP1 TARGETS UP
ST TYPE I INTERFERON PATHWAY
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
VART KSHV INFECTION ANGIOGENIC MARKERS UP
GILMORE CORE NFKB PATHWAY
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
BIOCARTA IL22BP PATHWAY
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
DAZARD UV RESPONSE CLUSTER G4
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
CORUM IL12A-IL12B-IL12RB1 COMPLEX
BIOCARTA ERYTH PATHWAY
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
WINTER HYPOXIA METAGENE
NEWMAN ERCC6 TARGETS UP
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX CHUK KPNA3 NFKB2 NFKBIB REL IKBKG NFKB1 NFKBIE RELB NFKBIA RELA TNIP2
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
FOSTER INFLAMMATORY RESPONSE LPS DN
FINETTI BREAST CANCER KINOME GREEN
GAURNIER PSMD4 TARGETS
FARMER BREAST CANCER CLUSTER 1
GRANDVAUX IFN RESPONSE NOT VIA IRF3
CORUM TUMOR NECROSIS FACTOR RECEPTOR 1 SIGNALING COMPLEX
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
NETPATH TNF ALPHA PATHWAY UP
MARKEY RB1 CHRONIC LOF DN
VETTER TARGETS OF PRKCA AND ETS1 DN
NOJIMA SFRP2 TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
TAVOR CEBPA TARGETS DN
LEE LIVER CANCER MYC E2F1 UP
NCI IL1PATHWAY
SESTO RESPONSE TO UV C3
REACTOME DEATH RECEPTOR SIGNALLING
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
NCI ANTHRAXPATHWAY
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
NETPATH IL 2 PATHWAY
ZHOU INFLAMMATORY RESPONSE FIMA UP
REACTOME VIRAL DSRNA TLR3 TRIF COMPLEX ACTIVATES RIP1
ROSTY CERVICAL CANCER PROLIFERATION CLUSTER
GRANDVAUX IRF3 TARGETS UP
REACTOME GPCR LIGAND BINDING
ZHU CMV ALL UP
GRUETZMANN PANCREATIC CANCER UP
NATSUME RESPONSE TO INTERFERON BETA UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
KEGG TYPE I DIABETES MELLITUS
AMIT EGF RESPONSE 60 MCF10A
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
NOJIMA SFRP2 TARGETS UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
WHITEFORD PEDIATRIC CANCER MARKERS
AUJLA IL22 AND IL17A SIGNALING
NCI NFKAPPABATYPICALPATHWAY
WALLACE PROSTATE CANCER RACE UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
WIELAND UP BY HBV INFECTION
ONDER CDH1 SIGNALING VIA CTNNB1
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
MAHADEVAN RESPONSE TO MP470 DN
UROSEVIC RESPONSE TO IMIQUIMOD
TSAI RESPONSE TO RADIATION THERAPY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
HARRIS HYPOXIA
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
CORUM CHUK-NFKB2-REL-IKBKG-SPAG9-NFKB1-NFKBIE-COPB2-TNIP1-NFKBIA-RELA-TNIP2 COMPLEX
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
RUIZ TNC TARGETS DN
SOUCEK MYC TARGETS
BIOCARTA DC PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
IZADPANAH STEM CELL ADIPOSE VS BONE UP
ZHAN MULTIPLE MYELOMA LB DN
KEGG AUTOIMMUNE THYROID DISEASE
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC UP
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
DER IFN ALPHA RESPONSE UP
LEE LIVER CANCER ACOX1 UP
BIOCARTA GSK3 PATHWAY
DAZARD UV RESPONSE CLUSTER G2
EINAV INTERFERON SIGNATURE IN CANCER
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
AMIT SERUM RESPONSE 40 MCF10A
BROWNE HCMV INFECTION 4HR UP
WONG ENDOMETRIAL CANCER LATE
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
BIOCARTA HSP27 PATHWAY
ZHU CMV 8 HR UP
GAUSSMANN MLL AF4 FUSION TARGETS F UP
SANA TNF SIGNALING UP
BIOCARTA INFLAM PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
XU HGF TARGETS INDUCED BY AKT1 6HR
ONDER CDH1 TARGETS 2 DN
CASTELLANO NRAS TARGETS UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
KEGG HEMATOPOIETIC CELL LINEAGE
KEGG CHEMOKINE SIGNALING PATHWAY
FUJII YBX1 TARGETS UP
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
JISON SICKLE CELL DISEASE UP
BIOCARTA CTLA4 PATHWAY
NCI NFKAPPABCANONICALPATHWAY
DASU IL6 SIGNALING UP
HUPER BREAST BASAL VS LUMINAL UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
ZHAN MULTIPLE MYELOMA HP UP
NCI PDGFRBPATHWAY
ZUCCHI METASTASIS DN
LU IL4 SIGNALING
AMUNDSON GAMMA RADIATION RESPONSE
YAMASHITA METHYLATED IN PROSTATE CANCER
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
ehrlichia chaffeensis wakullalactobacillus acidophilusbifidobacterium bifidumescherichia coliGeneSet Name
0.00006 0.01173 0.07512 0.00000NETPATH_IL_2_PATHWAY_UP
0.00022 0.00114 0.00007 0.00000NETPATH_IL_1_PATHWAY_UP
0.00020 0.00000 0.00000 0.00000NCI_IL23PATHWAY
0.00000 0.00012 0.00103 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.00004 0.00000 0.00000 0.00000NCI_IL27PATHWAY
0.00254 0.00006 0.00028 0.00026ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.00000 0.01511 0.05727 0.00129NETPATH_IL_4_PATHWAY_UP
0.00000 0.00372 0.01084 0.00000NETPATH_IL_3_PATHWAY_UP
0.00000 0.00006 0.00007 0.00000NETPATH_IL_6_PATHWAY_UP
0.00004 0.06237 0.01764 0.00000NETPATH_IL_7_PATHWAY_UP
0.00116 0.00427 0.00008 0.01389GERY_CEBP_TARGETS
0.00000 0.00000 0.00033 0.00000NCI_IL12_2PATHWAY
0.00000 0.01533 0.11144 0.00001NETPATH_IL_5_PATHWAY_UP
0.00163 0.02747 0.01529 0.00010NCI_CD40_PATHWAY
0.00000 0.01316 0.00572 0.00028NETPATH_IL_9_PATHWAY_UP
0.00001 0.01239 0.06861 0.01630NCI_IL12_STAT4PATHWAY
0.00114 0.00000 0.00000 0.00002BIOCARTA_IL10_PATHWAY
0.00547 0.00008 0.00214 0.00000GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00699 0.01221 0.00950 0.00000BIOCARTA_NFKB_PATHWAY
0.00447 0.00430 0.00474 0.00000MAHAJAN_RESPONSE_TO_IL1A_UP
0.08401 0.00000 0.00000 0.00000PUJANA_BRCA2_PCC_NETWORK
0.04046 0.05378 0.01898 0.00000WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.12285 0.13369 0.15558 0.02803BIOCARTA_IL6_PATHWAY
0.00000 0.00180 0.00101 0.00002KEGG_GRAFT_VERSUS_HOST_DISEASE
0.06530 0.00465 0.00099 0.00010NCI_TNFPATHWAY
0.00014 0.01634 0.01762 0.00015REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.00000 0.00000 0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.01394 0.02532 0.01532 0.00000BIOCARTA_IL1R_PATHWAY
0.00014 0.00414 0.13661 0.00000KRASNOSELSKAYA_ILF3_TARGETS_UP
0.00001 0.00034 0.00098 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00000 0.00000 0.00000 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.01247 0.00648 0.01539 0.00026IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.00042 0.00081 0.00190 0.00000AMIT_EGF_RESPONSE_40_HELA
0.00166 0.00070 0.00216 0.00001BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.03497 0.18043 0.13478 0.02480MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00174 0.09352 0.07330 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00001 0.00372 0.00139 0.00220TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.00001 0.00000 0.00013 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.04484 0.06788 0.10892 0.00016RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.00331 0.00000 0.00000 0.00000SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP
0.10384 0.08331 0.12054 0.02029CORUM_CD20-LCK-LYN-FYN-P75/80_COMPLEX_RAJI_HUMAN_B_CELL_LINE
0.11672 0.13048 0.06502 0.00331KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.00000 0.00000 0.00000 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.00053 0.00118 0.00292 0.00144XU_AKT1_TARGETS_6HR
0.00000 0.00000 0.00000 0.00000KANG_DOXORUBICIN_RESISTANCE_UP
0.07767 0.04784 0.03297 0.03704KEGG_TYPE_II_DIABETES_MELLITUS
0.00000 0.02070 0.10808 0.00647LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.00000 0.00017 0.00006 0.00000REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00000 0.00000 0.00442 0.00000SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.04824 0.03092 0.00439 0.00009BIOCARTA_CD40_PATHWAY
0.00001 0.00000 0.00000 0.00000DAUER_STAT3_TARGETS_DN
0.00031 0.03726 0.17262 0.00143RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.16910 0.07015 0.06366 0.02153DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.00037 0.09453 0.00402 0.00046AMIT_EGF_RESPONSE_120_HELA
0.00067 0.13620 0.10901 0.02480DANG_REGULATED_BY_MYC_DN
0.01515 0.00384 0.00140 0.05932BIOCARTA_RANKL_PATHWAY
0.00000 0.00667 0.00155 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.04964 0.03806 0.02644 0.00370IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP
0.00028 0.00831 0.00133 0.01026PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00007 0.08863 0.14393 0.03420KYNG_DNA_DAMAGE_UP
0.06659 0.11134 0.12969 0.06859CORUM_ABIN2-NFKB1-MAP3K8_COMPLEX
0.00000 0.00852 0.00724 0.00843LEE_LIVER_CANCER_E2F1_UP
0.00000 0.00489 0.02743 0.00002HELLER_SILENCED_BY_METHYLATION_UP
0.00001 0.00010 0.00013 0.00000BOWIE_RESPONSE_TO_TAMOXIFEN
0.10943 0.11168 0.14873 0.00791GOZGIT_ESR1_TARGETS_DN
0.00000 0.00084 0.00865 0.00769ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.00000 0.07352 0.13028 0.00006SMID_BREAST_CANCER_LUMINAL_B_DN
0.00012 0.00000 0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.03169 0.02529 0.02139 0.12623WONG_ENDMETRIUM_CANCER_UP
0.03289 0.00918 0.05128 0.06057FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.16009 0.05982 0.02230 0.01415CORUM_REL-MAP3K8-RELA-TNIP2-PAPOLA_COMPLEX
0.00000 0.03043 0.02011 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00000 0.03083 0.02793 0.00002BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00052 0.04481 0.09003 0.01653REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.10012 0.00000 0.00000 0.00000NCI_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
0.00000 0.00000 0.00000 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.13478 0.15119 0.17979 0.00701ZHANG_PROLIFERATING_VS_QUIESCENT
0.00020 0.02581 0.06060 0.00005HUMMEL_BURKITTS_LYMPHOMA_DN
0.00083 0.18253 0.05134 0.00067ST_STAT3_PATHWAY
0.00000 0.00000 0.00000 0.00000KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00860 0.01718 0.11172 0.00000KEGG_APOPTOSIS
0.02218 0.05429 0.17640 0.00288CORUM_NFKB1-NFKB2-REL-RELA-RELB_COMPLEX
0.00050 0.03196 0.05799 0.00492CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00151 0.01167 0.05376 0.00000HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00000 0.02479 0.01383 0.00000CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00006 0.00001 0.00000 0.00000MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.00196 0.14551 0.19891 0.01874NCI_ATF2_PATHWAY
0.00835 0.01133 0.08067 0.01122GEORGANTAS_HSC_MARKERS
0.00103 0.11821 0.17981 0.03091KEGG_PRIMARY_IMMUNODEFICIENCY
0.00000 0.00000 0.00000 0.00000ZHANG_INTERFERON_RESPONSE
0.02693 0.07144 0.17082 0.03525KONDO_PROSTATE_CANCER_WITH_H3K27ME3
0.00059 0.00682 0.08520 0.00015CHANG_IMMORTALIZED_BY_HPV31_DN
0.00288 0.00095 0.00982 0.01109KEGG_ASTHMA
0.00000 0.04711 0.01386 0.00003CROONQUIST_STROMAL_STIMULATION_UP
0.11433 0.03740 0.08409 0.13293KANG_GIST_WITH_PDGFRA_UP
0.00000 0.11812 0.07904 0.02879KHETCHOUMIAN_TRIM24_TARGETS_UP
0.00017 0.00009 0.00007 0.00004KIM_LRRC3B_TARGETS
0.06560 0.10069 0.10436 0.00108DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.00059 0.00495 0.00296 0.00002HORIUCHI_WTAP_TARGETS_UP
0.00000 0.10725 0.10663 0.12734RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.11413 0.01240 0.01392 0.01445BIOCARTA_SODD_PATHWAY
0.00009 0.00113 0.00394 0.00439BIOCARTA_TH1TH2_PATHWAY
0.00097 0.00000 0.00000 0.00009KEGG_JAK_STAT_SIGNALING_PATHWAY
0.01959 0.00234 0.00290 0.00126BUDHU_LIVER_CANCER_METASTASIS_DN
0.00000 0.00000 0.00000 0.00000CROONQUIST_NRAS_SIGNALING_DN
0.00356 0.00463 0.02695 0.01475TSAI_DNAJB4_TARGETS_UP
0.00003 0.04496 0.17576 0.04300MORI_PRE_BI_LYMPHOCYTE_DN
0.00214 0.00144 0.02261 0.00000DER_IFN_BETA_RESPONSE_UP
0.16010 0.08648 0.15536 0.14412CORUM_IL12B-IL12RB1-IL12RB2_COMPLEX
0.00056 0.00593 0.04303 0.00002DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.04314 0.03231 0.11299 0.02986NETPATH_IL_6_PATHWAY
0.00539 0.09243 0.10056 0.00000DIRMEIER_LMP1_RESPONSE_LATE_UP
0.00714 0.00139 0.00343 0.00018SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.04300 0.00000 0.00000 0.00002BIOCARTA_CYTOKINE_PATHWAY
0.01408 0.00830 0.03207 0.04486GALI_TP53_TARGETS_APOPTOTIC_UP
0.00332 0.17573 0.00645 0.19250MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.00000 0.00000 0.00006 0.00000BASSO_CD40_SIGNALING_UP
0.00264 0.14176 0.06403 0.00702TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00000 0.02256 0.05507 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.00004 0.15147 0.02397 0.00002MARZEC_IL2_SIGNALING_UP
0.00448 0.01164 0.04026 0.10036BIOCARTA_BLYMPHOCYTE_PATHWAY
0.11589 0.18728 0.11328 0.02814ZERBINI_RESPONSE_TO_SULINDAC_UP
0.03537 0.01551 0.05268 0.00089NCI_PTP1BPATHWAY
0.00094 0.02392 0.10021 0.00219WU_HBX_TARGETS_2_DN
0.00001 0.00272 0.00318 0.00000MAHADEVAN_RESPONSE_TO_MP470_UP
0.00000 0.19514 0.17152 0.13855SMID_BREAST_CANCER_NORMAL_LIKE_UP
0.00156 0.15133 0.05329 0.00016FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.00829 0.09391 0.06186 0.00058BIOCARTA_TID_PATHWAY
0.03422 0.00000 0.00000 0.00000PUJANA_XPRSS_INT_NETWORK
0.00000 0.00000 0.00000 0.00000SANA_RESPONSE_TO_IFNG_UP
0.00466 0.07388 0.05362 0.00000ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.00000 0.00174 0.00573 0.00028KEGG_LEISHMANIA_INFECTION
0.00000 0.03024 0.11977 0.05581BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.00291 0.04051 0.07447 0.00050CHEN_HOXA5_TARGETS_9HR_UP
0.03278 0.00434 0.02565 0.15918LIANG_SILENCED_BY_METHYLATION_UP
0.00000 0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00003 0.00000 0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.01806 0.00854 0.00015 0.08735CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.06472 0.03405 0.07657 0.01185BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.00000 0.00000 0.00000 0.00000MOSERLE_IFNA_RESPONSE
0.00000 0.00000 0.00000 0.00011FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.00252 0.01240 0.00436 0.00194BIOCARTA_ASBCELL_PATHWAY
0.00731 0.05963 0.11294 0.01565LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.00161 0.02705 0.13461 0.00611PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP
0.00000 0.00000 0.00000 0.00000CROONQUIST_IL6_DEPRIVATION_DN
0.06001 0.03458 0.03806 0.00089BIOCARTA_IL7_PATHWAY
0.00252 0.00033 0.00006 0.00000KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.00012 0.01385 0.01849 0.15379BIOCARTA_GRANULOCYTES_PATHWAY
0.05996 0.00403 0.00048 0.00004BIOCARTA_TNFR2_PATHWAY
0.11084 0.00318 0.05251 0.00116LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.00000 0.04650 0.09533 0.08966HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00131 0.12346 0.00784 0.01098ELVIDGE_HYPOXIA_BY_DMOG_UP
0.01445 0.14528 0.14093 0.01299BIOCARTA_IL2RB_PATHWAY
0.00265 0.00475 0.01525 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00001 0.01593 0.11780 0.00008BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.05667 0.00490 0.00481 0.01398NCI_ACTIVATION_OF_PRO_CASPASE_8
0.00473 0.03223 0.05087 0.00005RUTELLA_RESPONSE_TO_HGF_UP
0.00000 0.03599 0.13571 0.14286HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.00099 0.00031 0.00000 0.00005PRAMOONJAGO_SOX4_TARGETS_UP
0.00107 0.00034 0.00605 0.02690PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.04364 0.08170 0.11573 0.08745YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.00285 0.01418 0.04511 0.01149BIOCARTA_PML_PATHWAY
0.01105 0.00000 0.00000 0.00000GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP
0.00924 0.00084 0.03249 0.01464BIOCARTA_NO2IL12_PATHWAY
0.00000 0.00033 0.00117 0.00009TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.00004 0.07905 0.05369 0.00121REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.00000 0.00000 0.00000 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.00000 0.00000 0.00000 0.00000GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.13231 0.00810 0.00360 0.04442SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.00000 0.00000 0.00005 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.10950 0.10592 0.03028 0.00003NETPATH_IL_1_PATHWAY
0.00027 0.10353 0.02232 0.01124ELVIDGE_HYPOXIA_UP
0.00002 0.00487 0.03302 0.00003BIOCARTA_NKT_PATHWAY
0.00000 0.00000 0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.00000 0.12322 0.08284 0.00785NCI_IL6_7PATHWAY
0.00000 0.02614 0.15636 0.13298REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.00022 0.00492 0.00294 0.00141ROETH_TERT_TARGETS_UP
0.08132 0.06413 0.02138 0.00807TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00063 0.00383 0.01086 0.05748BIOCARTA_LAIR_PATHWAY
0.16376 0.00829 0.05475 0.00110NUYTTEN_NIPP1_TARGETS_UP
0.16006 0.05556 0.08675 0.13309ST_TYPE_I_INTERFERON_PATHWAY
0.00000 0.00000 0.00000 0.00000KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.01577 0.00138 0.00397 0.00000VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.02155 0.00978 0.06213 0.00003GILMORE_CORE_NFKB_PATHWAY
0.00144 0.00089 0.00779 0.00000NUYTTEN_EZH2_TARGETS_UP
0.00000 0.00233 0.00215 0.00000DUTTA_APOPTOSIS_VIA_NFKB
0.02837 0.00107 0.00102 0.00003BIOCARTA_IL22BP_PATHWAY
0.00000 0.00007 0.00294 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.00650 0.00091 0.00551 0.00000DER_IFN_GAMMA_RESPONSE_UP
0.04480 0.06793 0.04390 0.16523DAZARD_UV_RESPONSE_CLUSTER_G4
0.00181 0.00200 0.00179 0.00010KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.00000 0.00000 0.00000 0.00000BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00039 0.00000 0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00507 0.00174 0.01033 0.00000ONDER_CDH1_TARGETS_3_DN
0.00006 0.12763 0.08197 0.01985RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.16334 0.07771 0.11380 0.16073CORUM_IL12A-IL12B-IL12RB1_COMPLEX
0.03887 0.00077 0.00013 0.00332BIOCARTA_ERYTH_PATHWAY
0.00000 0.01636 0.13644 0.04537NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.01067 0.11168 0.01386 0.02164WINTER_HYPOXIA_METAGENE
0.00209 0.06163 0.19779 0.00184NEWMAN_ERCC6_TARGETS_UP
0.03294 0.00206 0.00667 0.00012CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_CHUK_KPNA3_NFKB2_NFKBIB_REL_IKBKG__NFKB1_NFKBIE_RELB__NFKBIA_RELA_TNIP2
0.13273 0.08350 0.06736 0.10160GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.00000 0.00000 0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00027 0.19498 0.12797 0.05690FINETTI_BREAST_CANCER_KINOME_GREEN
0.00000 0.00000 0.00007 0.00000GAURNIER_PSMD4_TARGETS
0.00000 0.00000 0.00019 0.00000FARMER_BREAST_CANCER_CLUSTER_1
0.00070 0.00046 0.00064 0.00002GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.12925 0.17165 0.10994 0.17457CORUM_TUMOR_NECROSIS_FACTOR_RECEPTOR_1_SIGNALING_COMPLEX
0.04099 0.01124 0.02093 0.00071SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.11655 0.09704 0.11156 0.00001NETPATH_TNF_ALPHA_PATHWAY_UP
0.00000 0.03135 0.07695 0.09710MARKEY_RB1_CHRONIC_LOF_DN
0.08455 0.11525 0.07808 0.00161VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
0.00758 0.00035 0.05582 0.00025NOJIMA_SFRP2_TARGETS_DN
0.00009 0.01424 0.07807 0.00011AMIT_SERUM_RESPONSE_120_MCF10A
0.05336 0.05965 0.05786 0.14255TAVOR_CEBPA_TARGETS_DN
0.00000 0.00992 0.02392 0.08000LEE_LIVER_CANCER_MYC_E2F1_UP
0.06247 0.02751 0.00356 0.00686NCI_IL1PATHWAY
0.01412 0.02540 0.00136 0.00001SESTO_RESPONSE_TO_UV_C3
0.01485 0.00039 0.00063 0.00004REACTOME_DEATH_RECEPTOR_SIGNALLING
0.00022 0.00027 0.00426 0.00000GEISS_RESPONSE_TO_DSRNA_UP
0.00030 0.00001 0.00145 0.00000GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.16870 0.01020 0.03876 0.08580NCI_ANTHRAXPATHWAY
0.00050 0.12179 0.14936 0.00653SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.06742 0.03188 0.09338 0.00003CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.02892 0.05006 0.08923 0.01452NETPATH_IL_2_PATHWAY
0.02576 0.00018 0.00015 0.00000ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.06957 0.09858 0.10912 0.00018REACTOME_VIRAL_DSRNA_TLR3_TRIF_COMPLEX_ACTIVATES_RIP1
0.00000 0.00000 0.00000 0.00000ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER
0.00031 0.01163 0.02965 0.00002GRANDVAUX_IRF3_TARGETS_UP
0.01107 0.07560 0.07753 0.00318REACTOME_GPCR_LIGAND_BINDING
0.00083 0.00466 0.03180 0.00000ZHU_CMV_ALL_UP
0.00009 0.09339 0.12988 0.02087GRUETZMANN_PANCREATIC_CANCER_UP
0.08675 0.00828 0.06876 0.06156NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.00011 0.04137 0.02142 0.00010LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.05878 0.09324 0.00003NAGASHIMA_EGF_SIGNALING_UP
0.00184 0.00022 0.00021 0.00002KEGG_TYPE_I_DIABETES_MELLITUS
0.00070 0.00978 0.00467 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.00000 0.00000 0.00000 0.00000KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00340 0.00685 0.00005 0.00018NOJIMA_SFRP2_TARGETS_UP
0.00301 0.00598 0.01391 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.00101 0.00000 0.00000 0.00000WHITEFORD_PEDIATRIC_CANCER_MARKERS
0.01045 0.00386 0.00419 0.00129AUJLA_IL22_AND_IL17A_SIGNALING
0.03445 0.01289 0.06268 0.00288NCI_NFKAPPABATYPICALPATHWAY
0.00000 0.00000 0.00167 0.00004WALLACE_PROSTATE_CANCER_RACE_UP
0.00000 0.00000 0.00005 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.00000 0.00048 0.02002 0.00002WIELAND_UP_BY_HBV_INFECTION
0.02499 0.05066 0.13470 0.00015ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.02715 0.02475 0.02725 0.01179GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.08720 0.00321 0.00016 0.00317MAHADEVAN_RESPONSE_TO_MP470_DN
0.00001 0.00000 0.00005 0.00000UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.00053 0.00010 0.00063 0.00005TSAI_RESPONSE_TO_RADIATION_THERAPY
0.00000 0.00000 0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00025 0.18721 0.05400 0.00034HARRIS_HYPOXIA
0.00000 0.00020 0.00457 0.00002FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.03043 0.01629 0.07888 0.00004CORUM_CHUK-NFKB2-REL-IKBKG-SPAG9-NFKB1-NFKBIE-COPB2-TNIP1-NFKBIA-RELA-TNIP2_COMPLEX
0.02669 0.09320 0.11437 0.00007KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.00009 0.00000 0.00000 0.18340RUIZ_TNC_TARGETS_DN
0.00027 0.00010 0.00012 0.00037SOUCEK_MYC_TARGETS
0.01675 0.00170 0.00573 0.00672BIOCARTA_DC_PATHWAY
0.01086 0.02438 0.00389 0.05842TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.00408 0.19490 0.10012 0.00049IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.00000 0.00182 0.01616 0.00002ZHAN_MULTIPLE_MYELOMA_LB_DN
0.00607 0.00927 0.00055 0.00009KEGG_AUTOIMMUNE_THYROID_DISEASE
0.00101 0.00319 0.06300 0.17340TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.00024 0.00628 0.00118 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.00000 0.00000 0.00000 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.00307 0.00259 0.00011 0.00003DAUER_STAT3_TARGETS_UP
0.00122 0.00000 0.00081 0.00000DER_IFN_ALPHA_RESPONSE_UP
0.00000 0.05143 0.00208 0.13289LEE_LIVER_CANCER_ACOX1_UP
0.07890 0.08861 0.16284 0.16529BIOCARTA_GSK3_PATHWAY
0.00111 0.06213 0.03296 0.00004DAZARD_UV_RESPONSE_CLUSTER_G2
0.00004 0.00000 0.00000 0.00000EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.00000 0.01242 0.00444 0.00002MCLACHLAN_DENTAL_CARIES_DN
0.00014 0.00026 0.00011 0.00000KEGG_ALLOGRAFT_REJECTION
0.00005 0.00031 0.01845 0.00142AMIT_SERUM_RESPONSE_40_MCF10A
0.01785 0.03781 0.10226 0.00000BROWNE_HCMV_INFECTION_4HR_UP
0.03615 0.01701 0.05377 0.06386WONG_ENDOMETRIAL_CANCER_LATE
0.00000 0.00000 0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.01244 0.07152 0.19777 0.05549BIOCARTA_HSP27_PATHWAY
0.00000 0.00000 0.00006 0.00000ZHU_CMV_8_HR_UP
0.13245 0.15190 0.16417 0.02986GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.00000 0.00000 0.00000 0.00000SANA_TNF_SIGNALING_UP
0.00595 0.00000 0.00002 0.00000BIOCARTA_INFLAM_PATHWAY
0.00084 0.00000 0.00019 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.00223 0.11695 0.04693 0.00014XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.00036 0.02211 0.09938 0.00002ONDER_CDH1_TARGETS_2_DN
0.00260 0.00308 0.00034 0.00040CASTELLANO_NRAS_TARGETS_UP
0.00004 0.11701 0.02116 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00974 0.01605 0.00313 0.03679SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.00000 0.02072 0.03856 0.00021KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.00000 0.03796 0.10844 0.00217KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.03830 0.00630 0.00024 0.02740FUJII_YBX1_TARGETS_UP
0.00336 0.03748 0.08234 0.00044UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00000 0.00011 0.00331 0.00023JISON_SICKLE_CELL_DISEASE_UP
0.03759 0.06223 0.00424 0.06958BIOCARTA_CTLA4_PATHWAY
0.02559 0.00905 0.01890 0.00009NCI_NFKAPPABCANONICALPATHWAY
0.03956 0.15237 0.05109 0.00015DASU_IL6_SIGNALING_UP
0.11431 0.18179 0.02537 0.00000HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.00009 0.00000 0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00000 0.00249 0.11568 0.02203ZHAN_MULTIPLE_MYELOMA_HP_UP
0.03222 0.07546 0.15310 0.12159NCI_PDGFRBPATHWAY
0.00899 0.04132 0.03751 0.00000ZUCCHI_METASTASIS_DN
0.00009 0.00007 0.01831 0.00649LU_IL4_SIGNALING
0.03272 0.00000 0.00000 0.00000AMUNDSON_GAMMA_RADIATION_RESPONSE
0.02573 0.19462 0.00294 0.00355YAMASHITA_METHYLATED_IN_PROSTATE_CANCER